BioSpace News Archive

Drug Development

Janssen Provides Update on IMBRUVICA® (ibrutinib) Phase 3 PHOENIX Trial in Newly Diagnosed Non-Germinal Center B Cell (Non-GCB) Subtype of Diffuse Large B-Cell Lymphoma (DLBCL)

The clinical trial did not meet the primary endpoint of event-free survival in patients with non-GCB subtype of DLBCL

July 11, 2018
·
12 min read
Drug Development

AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICA®) in Blood Cancer Diffuse Large B-Cell Lymphoma (DLBCL) and Ongoing Ibrutinib Clinical Program

The ibrutinib clinical program is designed to fully explore the potential of this first-in-class molecule as a single or combination therapy for multiple cancers and other diseases. Fourteen Phase 3 company-sponsored studies are ongoing.

July 11, 2018
·
13 min read
BioMidwest

Cingulate Therapeutics Announces $7.5M Equity Investment from Werth Family Investment Associates

Industry veteran Peter J. Werth to join Cingulate Therapeutics Board of Directors

July 11, 2018
·
4 min read
Drug Development

Phase 3 Trial of NINLARO® (ixazomib) as Maintenance Therapy Met Primary Endpoint Demonstrating Statistically Significant Improvement in Progression-Free Survival in Patients with Multiple Myeloma Post-Transplant

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the randomized, Phase 3 TOURMALINE-MM3 study met its primary endpoint.

July 11, 2018
·
9 min read
Business

Bioasis and BioAgilytix Announce Strategic Collaboration to Advance xB3 TM-001, Bioasis’ Lead Investigational Candidate to Treat HER2+ Brain Cancer, to IND Submission and into the Clinic

Bioasis and BioAgilytix today announced a strategic collaboration to partner on the development and validation of bioanalytical methods to support and advance the xB3 TM-001 program.

July 11, 2018
·
6 min read
Drug Development

OncoNano Announces Dosing of Patients in Phase 1 Clinical Trial with ONM-100, an Intraoperative Imaging Agent that Targets Tumor Acidosis for the Detection of Solid Tumors

Study, being conducted at TRACER Center of Expertise, University Medical Center in Groningen, The Netherlands, is evaluating safety, pharmacokinetics and feasibility to detect residual tumors and lymph nodes often missed by surgeons

July 11, 2018
·
3 min read
Biotech Beach

iSchemaView Brings RAPID™ Imaging Platform to Australia and New Zealand Through Exclusive Distributor, Diagnostic Imaging Australia

State-of-the-Art Imaging Solution Provides Automated Scoring and Assessment of Brain Ischemia — Expanding the Treatment Window for Certain Acute Ischemic Strokes to Twenty-Four Hours After Onset

July 11, 2018
·
4 min read
Business

Dr. Milan Mrksich Joins SLAS Technology’s Scientific Advisory Board

SAMDI Tech Inc. is pleased to announce that Dr. Milan Mrksich, founder of SAMDI Tech and professor at Northwestern University, has been selected to serve as a scientific advisor for SLAS Technology.

July 11, 2018
·
1 min read
Drug Development

Seattle Genetics Announces Publication of Results from Two Tucatinib Phase 1b Clinical Trials in HER2-Positive Metastatic Breast Cancer

Results of Combination “Triplet” of Tucatinib with Trastuzumab and Capecitabine Published in The Lancet Oncology

July 11, 2018
·
10 min read
Business

Teva to Report Second Quarter 2018 Financial Results on August 2, 2018

Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to discuss its second quarter 2018 results and overall business environment.

July 11, 2018
·
6 min read